Search results for "psychosis."

showing 10 items of 317 documents

Alterations of perineuronal nets in the dorsolateral prefrontal cortex of neuropsychiatric patients

2019

Abstract Background Alterations in the structure and physiology of interneurons in the prefrontal cortex (PFC) are important factors in the etiopathology of different psychiatric disorders. Among the interneuronal subpopulations, parvalbumin (PV) expressing cells appear to be specially affected. Interestingly, during development and adulthood the connectivity of these interneurons is regulated by the presence of perineuronal nets (PNNs), specialized regions of the extracellular matrix, which are frequently surrounding PV expressing neurons. Previous reports have found anomalies in the density of PNNs in the PFC of schizophrenic patients. However, although some studies have described alterat…

0301 basic medicinePsychosisBipolar disorderPerineuronal netsPrefrontal cortexlcsh:RC321-57103 medical and health sciences0302 clinical medicinemental disordersNeuroplasticitymedicineMajor depressionPsiquiatriaBipolar disorderPrefrontal cortexlcsh:Neurosciences. Biological psychiatry. NeuropsychiatrySalut mentalBiological PsychiatryParvalbuminbiologyResearchPerineuronal netlcsh:QP351-495medicine.diseaseDorsolateral prefrontal cortexPsychiatry and Mental healthlcsh:Neurophysiology and neuropsychology030104 developmental biologymedicine.anatomical_structurenervous systemSchizophreniaSchizophreniabiology.proteinEsquizofrèniaNeuroscience030217 neurology & neurosurgeryParvalbuminInternational Journal of Bipolar Disorders
researchProduct

Cognitive functioning throughout adulthood and illness stages in individuals with psychotic disorders and their unaffected siblings

2021

The European Community’s Seventh Framework Programme under grant agreement No. HEALTH-F2-2010-241909 (EUGEI); The Spanish sample was supported by the Spanish Ministry of Science and Innovation, Instituto de Salud Carlos III (SAM16PE07CP1, PI16/02012, PI19/024) (...)

0301 basic medicinevaliditymedicine.medical_treatmentCHILDHOODNeuropsychological TestsFAMÍLIAepisodeCognition0302 clinical medicineDEFICITSSettore MED/48 -Scienze Infermierist. e Tecn. Neuro-Psichiatriche e Riabilitat.MedicineCognitive impairmentPsychiatrySymptom severityCannabis useIMPAIRMENTABILITYPsychiatry and Mental healthSchizophreniaRELIABILITYNeuropsychological TestLife Sciences & BiomedicineHumanClinical psychologyAdultBiochemistry & Molecular Biologyimpairmentschizophrenia-patientsabilityGENETIC RISKPsychotic DisorderSCHIZOPHRENIA-PATIENTS03 medical and health sciencesCellular and Molecular NeuroscienceSDG 3 - Good Health and Well-beingSettore M-PSI/08 - Psicologia ClinicaHumansIn patientCognitive skillVALIDITYAntipsychoticMolecular BiologySettore MED/25 - PsichiatriaAgedCross-Sectional StudieDECLINEScience & Technologyreliabilitybusiness.industryWorking memorySiblingsNeurosciencesDiagnostic markersmedicine.diseaseCross-Sectional Studies030104 developmental biologydeficitsPsychotic DisordersSchizophreniaPSYCHOSIS COGNITION MULTICENTRIC STUDYNeurosciences & NeurologybusinessEPISODE030217 neurology & neurosurgeryMolecular Psychiatry
researchProduct

How do people talk decades later about their crisis that we call psychosis? : A qualitative study of the personal meaning-making process

2019

Psychosis refers to a severe mental state that often significantly affects the individual’s life course. However, it remains unclear how people with the lived experiences themselves view these phenomena, as part of their life story. In order to evaluate this personal meaning-making process, we conducted in-depth life-story interviews with 20 people who had been diagnosed with non-affective psychosis 10 to 23 years previously in one catchment area. 35% of them were still receiving mental health treatment, and 55% of them were diagnosed with schizophrenia. Only a minority named their experiences as psychosis. On the basis of narrative analysis, two types of stories appeared to encompass how m…

050103 clinical psychologyPsychosisProcess (engineering)kokemuskerrontalong-term follow-upDevelopmental psychology03 medical and health sciences0302 clinical medicinemedicineMeaning-making0501 psychology and cognitive sciencesfirst-person accountautobiographyelämänhistoriaskitsofreniapsykoositLived experience05 social sciencesopen dialoguemedicine.disease030227 psychiatryPsychiatry and Mental healthSchizophreniaMental stateLife course approachseurantatutkimusPsychologykvalitatiivinen tutkimusQualitative research
researchProduct

O2.1. FIRST EPISODE PSYCHOSIS PATIENTS ACROSS EUROPE DIFFER IN INTELLECTUAL QUOTIENT (IQ) AND EXPOSURE TO ENVIRONMENTAL HAZARDS

2018

Abstract Background Children who later develop Schizophrenia on average are more likely to present with lower IQ; this has been considered evidence for the neurodevelopmental theory of schizophrenia. Though, recent studies have shown that first episode psychosis patients with a history of cannabis use have significantly higher premorbid and current IQ compared to those who never used it. This suggests that abnormal early neurodevelopment does not explain the aetiology of all cases of Schizophrenia, leaving space to environmental hazards. The present study aims to: investigate differences in IQ, as a marker of neurodevelopment, and in exposure to environmental risk factors in a large sample …

AbstractsPsychiatry and Mental healthmedicine.medical_specialtyFirst episode psychosismedicinePsychiatryPsychologyO2. Oral Session: CognitionIntellectual quotientSchizophrenia Bulletin
researchProduct

Transdiagnostic dimensions of psychopathology at first episode psychosis: findings from the multinational EU-GEI study.

2019

Background\ud The value of the nosological distinction between non-affective and affective psychosis has frequently been challenged. We aimed to investigate the transdiagnostic dimensional structure and associated characteristics of psychopathology at First Episode Psychosis (FEP). Regardless of diagnostic categories, we expected that positive symptoms occurred more frequently in ethnic minority groups and in more densely populated environments, and that negative symptoms were associated with indices of neurodevelopmental impairment.\ud \ud Method\ud This study included 2182 FEP individuals recruited across six countries, as part of the EUropean network of national schizophrenia networks st…

AdultAffective Disorders PsychoticMaleBipolar Disorder[SDV.NEU.NB]Life Sciences [q-bio]/Neurons and Cognition [q-bio.NC]/NeurobiologyBifactor modelPsicosiModels Psychologicalsymptom dimensionsPathological psychologyYoung AdultSettore M-PSI/08 - Psicologia Clinicafirst episode psychosisSettore MED/48 -Scienze Infermierist. e Tecn. Neuro-Psichiatriche e Riabilitat.HumansSettore MED/25 - PsichiatriaComputingMilieux_MISCELLANEOUSPsychiatric Status Rating ScalesPsychopathology[SDV.NEU.PC]Life Sciences [q-bio]/Neurons and Cognition [q-bio.NC]/Psychology and behaviorDepression[SCCO.NEUR]Cognitive science/NeurosciencePsychoses[SDV.NEU.SC]Life Sciences [q-bio]/Neurons and Cognition [q-bio.NC]/Cognitive SciencesBifactor model; diagnostic categories; first episode psychosis; psychopathology; symptom dimensionsOriginal Articlespsychopathologydiagnostic categoriesPsicopatologiaEuropediagnostic categoriePsychotic DisordersROC Curvefirst episode psychosiSchizophreniaFemaleSchizophrenic PsychologyEsquizofrènia
researchProduct

Structural Covariance of Cortical Gyrification at Illness Onset in Treatment Resistance: A Longitudinal Study of First-Episode Psychoses

2021

AbstractTreatment resistance (TR) in patients with first-episode psychosis (FEP) is a major cause of disability and functional impairment, yet mechanisms underlying this severe disorder are poorly understood. As one view is that TR has neurodevelopmental roots, we investigated whether its emergence relates to disruptions in synchronized cortical maturation quantified using gyrification-based connectomes. Seventy patients with FEP evaluated at their first presentation to psychiatric services were followed up using clinical records for 4 years; of these, 17 (24.3%) met the definition of TR and 53 (75.7%) remained non-TR at 4 years. Structural MRI images were obtained within 5 weeks from first…

AdultAffective Disorders PsychoticMalePsychosisLongitudinal studymedicine.medical_specialtyAdolescentlongitudinalAcademicSubjects/MED00810treatment-resistantYoung Adult03 medical and health sciences0302 clinical medicineInternal medicinemedicineHumansLongitudinal Studiesfirst-episode psychosisGyrificationClozapineCerebral CortexFirst episodeclozapinebusiness.industryFunctional data analysisgyrificationmedicine.diseaseMagnetic Resonance Imaging030227 psychiatryschizophreniaPsychiatry and Mental healthPsychotic DisordersSchizophreniaConnectomeCardiologyFemaleNerve Netbusiness030217 neurology & neurosurgeryAntipsychotic AgentsFollow-Up StudiesRegular ArticlesMRImedicine.drugSchizophrenia Bulletin
researchProduct

Schizoaffective disorder and affective disorders with mood-incongruent psychotic features: keep separate or combine? Evidence from a family study.

1992

Objective This study investigated whether the distinction between schizoaffective disorder and affective disorders with mood-incongruent psychotic features as described in DSM-III-R is reflected by aggregation of schizophrenia in the families of probands with the former disorder and aggregation of affective disorders mainly among the relatives of probands with the latter type of disorders. Method The probands were 118 inpatients with definite lifetime diagnoses of DSM-III-R schizoaffective disorder or a major mood disorder with incongruent psychotic features according to structured clinical interviews. Diagnostic information on 475 of the probands' first-degree relatives was gathered throug…

AdultAffective Disorders PsychoticMalePsychosismedicine.medical_specialtyBipolar DisorderPopulationSchizoaffective disorderbehavioral disciplines and activitiesSeverity of Illness IndexPrevalence of mental disordersRisk FactorsTerminology as Topicmental disordersmedicineHumansFamilyFamily historyeducationPsychiatryPsychiatric Status Rating Scaleseducation.field_of_studyDepressive DisorderFamily aggregationMiddle Agedmedicine.diseaseHospitalizationPsychiatry and Mental healthMoodPsychotic DisordersSchizophreniaSchizophreniaFemalePsychologyClinical psychologyThe American journal of psychiatry
researchProduct

Daily use, especially of high-potency cannabis, drives the earlier onset of psychosis in cannabis users.

2013

UNLABELLED: Cannabis use is associated with an earlier age of onset of psychosis (AOP). However, the reasons for this remain debated. METHODS: We applied a Cox proportional hazards model to 410 first-episode psychosis patients to investigate the association between gender, patterns of cannabis use, and AOP. RESULTS: Patients with a history of cannabis use presented with their first episode of psychosis at a younger age (mean years = 28.2, SD = 8.0; median years = 27.1) than those who never used cannabis (mean years = 31.4, SD = 9.9; median years = 30.0; hazard ratio [HR] = 1.42; 95% CI: 1.16-1.74; P < .001). This association remained significant after controlling for gender (HR = 1.39; 95% …

AdultAffective Disorders PsychoticMaleRiskage of onset cannabis drug use gender high-potency cannabis psychotic disorders survival plotsPsychosisPediatricsmedicine.medical_specialtySex FactorsDelta-9-tetrahydrocannabinolSettore MED/48 -Scienze Infermierist. e Tecn. Neuro-Psichiatriche e Riabilitat.medicineHumansAge of OnsetPsychiatrySettore MED/25 - PsichiatriaCannabisFirst episodebiologyProportional hazards modelHazard ratioRegular Articlemedicine.diseasebiology.organism_classificationPsychiatry and Mental healthPsychotic DisordersSchizophreniaFemaleCannabisAge of onsetPsychologySchizophrenia bulletin
researchProduct

Correlative gene expression pattern linking RNF123 to cellular stress–senescence genes in patients with depressive disorder: Implication of DRD1 in t…

2013

Abstract Background The expression level of the RNF1213 gene in blood cells has been identified as a disease risk marker, more than ten years before the diagnosis of depression ( Glahn et al., 2012 ). To explore the status of this gene in the acute depressive state we have quantified the expression of RNF123 in the blood leukocytes ( N =17), dorsolateral prefrontal and cingulate cortex ( N =24) of patients with diagnosed depression and of matched controls. We have measured the expression of the DRD1 gene as a “neuronal probe”. We have also quantified the mRNA of six genes previously identified as markers of the biopsychological stress associated with major depression: FOS, DUSP1, OGG1, STMN…

AdultCingulate cortexSenescencemedicine.medical_specialtyPsychosisUbiquitin-Protein LigasesPsychotic depressionYoung AdultDopamineInternal medicineGene expressionLeukocytesmedicineHumansRNA MessengerDepression (differential diagnoses)Cerebral CortexDepressive Disorder MajorReceptors Dopamine D1Middle Agedmedicine.diseasePsychiatry and Mental healthClinical PsychologyEndocrinologymedicine.anatomical_structureCerebral cortexFemaleTranscriptomePsychologyNeuroscienceStress Psychologicalmedicine.drugJournal of Affective Disorders
researchProduct

Brief assessment of schizotypal traits: A multinational study

2018

The Schizotypal Personality Questionnaire-Brief (SPQ-B) was developed with the aim of examining variations in healthy trait schizotypy, as well as latent vulnerability to psychotic-spectrum disorders. No previous study has studied the cross-cultural validity of the SPQ-B in a large cross-national sample. The main goal of the present study was to analyze the reliability and the internal structure of SPQ-B scores in a multinational sample of 28,426 participants recruited from 14 countries. The mean age was 22.63. years (SD = 7.08; range 16-68. years), 37.7% (n = 10,711) were men. The omega coefficients were high, ranging from 0.86 to 0.92 for the total sample. Confirmatory factor analysis rev…

AdultCross-Cultural ComparisonMaleAdolescentPersonality InventoryPsychometricsSchizotypymedia_common.quotation_subjectSPQ-BCross-cultural; Psychosis; Psychosis risk; Schizotypal personality; Schizotypy; SPQ-BSample (statistics)Interpersonal communicationDevelopmental psychologySchizotypal Personality Disorder03 medical and health sciencesYoung AdultSchizotypy0302 clinical medicinePersonalityHumansMeasurement invariancePsychosis riskBiological Psychiatrymedia_commonAgedPsychiatric Status Rating ScalesSchizotypal personalityReproducibility of ResultsCross-culturalMiddle AgedPsychosisMental healthConfirmatory factor analysis030227 psychiatryPsychiatry and Mental healthTraitFemalePsychologyFactor Analysis Statistical030217 neurology & neurosurgery
researchProduct